Shrutimita Pokhariyal, Speaker at Dermatology Conference
Symbio, India
Title : Unravelling complex dermatology: Challenging diagnoses and the power of visuals

Abstract:

Accurate diagnosis and clinical vigilance are vital in complex dermatology. Generalized pruritus (itching) without visible skin lesions is often dismissed as benign but can signal hidden malignancies. Studies show patients with chronic pruritus have up to six times higher odds of undiagnosed cancer. A misdiagnosis such as mistaking shingles for bullous pemphigoid underscores the need to revisit initial assumptions when symptoms evolve unexpectedly. Neutrophilic dermatoses like Sweet’s syndrome and pyoderma gangrenosum also pose diagnostic challenges. Severe variants, such as necrotizing neutrophilic dermatosis, mimic life-threatening infections like necrotizing fasciitis but require immunosuppressive treatment, not surgery. Conversely, infections like sporotrichosis can mimic autoimmune skin disease, and if misdiagnosed, immunosuppressive therapy can worsen outcomes. One review found nearly 17% of pyoderma gangrenosum cases were infections, emphasizing the importance of biopsy and cultures. Visual diagnosis, a core pillar in dermatology, is vulnerable to misinterpretation especially when image references lack diversity. Conditions often appear differently across skin tones. The 2022 mpox outbreak illustrated how sharing diverse lesion images significantly improved diagnostic accuracy. AI tools trained on inclusive datasets can support clinicians by flagging atypical presentations. In one study, an AI model reached >80% sensitivity and 90% specificity in identifying mpox lesions. Biostatistics and predictive analytics are rapidly transforming dermatologic care. Machine learning models are being developed to predict severe drug reactions, supporting early intervention. Statistical modeling also aids in advancing targeted therapies, such as KIT D816V inhibitors for adult cutaneous mastocytosis. Together, thorough clinical evaluation, diverse imagery, robust biostatistics, and AI integration represent the future of dermatologic precision. These approaches enhance diagnostic accuracy, reduce misdiagnosis, and enable more personalized treatment strategies—ultimately improving outcomes for patients with complex skin disorders.

Biography:

Shrutimita Pokhariyal is a Principal Statistician at Symbio, a global CRO, with over 14 years of expertise in clinical research and biostatistics. She holds a Master's in Biostatistics from the University of Baroda and is known for her leadership in data-driven strategy, trial design, and predictive modelling. Shrutimita mentors aspiring biostatisticians and promotes diversity and women in STEM. She has represented Symbio at elite events like PHUSE EU Connect 2024 and 2025, IDC 2025 (as moderator and speaker), and delivers impactful webinars and trainings.

 

Watsapp